Further in vivo and in vitro studies are needed to investigate whether increased E-selectin levels, which reflect endothelial activation and platelet aggregation, initiate AF and AF-related thrombosis or are simply a consequence of AF-accompanied cardiovascular disease and adverse clinical events. The gene discussed is SELE; the disease is cardiovascular disorder.